Biomarkers: Saliva proteomics is a promising tool to study Sjögren syndrome

Nature Reviews Rheumatology

Volumn 11, Issue 4, 2015, Pages 202-203

  Tzioufas, Athanasios G ^a   Kapsogeorgou, Efstathia K ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLUSTERIN; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 5; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

AUTOIMMUNITY; B LYMPHOCYTE; CANCER RISK; CELL INFILTRATION; CLINICAL PRACTICE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE MARKER; GERMINAL CENTER; GLOMERULONEPHRITIS; HEALTH CARE COST; HEPATITIS; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; INTERSTITIAL NEPHRITIS; NONHODGKIN LYMPHOMA; PERIPHERAL NEUROPATHY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; PUBLICATION; PURPURA; RHEUMATOID ARTHRITIS; SALIVA LEVEL; SALIVARY GLAND; SALIVARY GLAND BIOPSY; SHORT SURVEY; SJOEGREN SYNDROME; VASCULITIS; FEMALE; METABOLISM; SALIVA; SJOGREN'S SYNDROME;

FEMALE; HUMANS; SALIVA; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 84926406669     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2015.10     Document Type: Short Survey

References (10)

1. Delaleu, N. et al. High fidelity between saliva proteomics and the salivary glands' biological state defines biomarker-signatures for primary Sjögren's syndrome. Arthritis Rheumatol. http://dx.doi.org/10.1002/art.39015 (2014).
2. Tzioufas, A. G., Kapsogeorgou, E. K. & Moutsopoulos, H. M. Pathogenesis of Sjögren's syndrome: what we know and what we should learn. J. Autoimmun. 39, 4-8 (2012).
3. Baimpa, E., Dahabreh, I. J., Voulgarelis, M. & Moutsopoulos, H. M. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88, 284-293 (2009).
4. Theander, E. et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome. Ann. Rheum. Dis. 70, 1363-1368 (2011).
5. Baldini, C. et al. Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome. Clin. Exp. Rheumatol. 30, 785-790 (2012).
6. Gerli, R. et al. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. Br. J. Rheumatol. 36, 969-975 (1997).
7. Christodoulou, M. I., Kapsogeorgou, E. K. & Moutsopoulos, H. M. Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J. Autoimmun. 34, 400-407 (2010).
8. Manoussakis, M. N. et al. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum. 56, 3977-3988 (2007).
9. Kapsogeorgou, E. K. et al. Minor salivary gland inflammatory lesions in Sjögren syndrome: do they evolve? J. Rheumatol. 40, 1566-1571 (2013).
10. Tzioufas, A. G. & Voulgarelis, M. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract. Res. Clin. Rheumatol. 21, 989-1010 (2007).